A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19

A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19

<p><strong>Background</strong> No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2.</p> <p><strong>Methods</strong> We conducted a randomized, controlled, open-label trial involving hospitalized adult pati...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Cao, B, Wang, Y, Wen, D, Liu, W, Wang, J, Fan, G, Ruan, L, Song, B, Cai, Y, Wei, M, Li, X, Xia, J, Chen, N, Xiang, J, Yu, T, Bai, T, Xie, X, Zhang, L, Li, C, Yuan, Y, Chen, H, Li, H, Huang, H, Tu, S, Gong, F, Liu, Y, Wei, Y, Dong, C, Zhou, F, Gu, X, Xu, J, Liu, Z, Zhang, Y, Shang, L, Wang, K, Li, K, Zhou, X, Dong, X, Qu, Z, Lu, S, Hu, X, Ruan, S, Luo, S, Wu, J, Peng, L, Cheng, F, Pan, L, Zou, J, Jia, C, Horby, PW, Et al.
Aineistotyyppi: Journal article
Kieli:English
Julkaistu: Massachusetts Medical Society 2020

Samankaltaisia teoksia